home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,170 rows where filing_year = 2022 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • third_quarter 299
  • second_quarter 297
  • fourth_quarter 288
  • first_quarter 286

issue_code 1

  • PHA · 1,170 ✖

filing_year 1

  • 2022 · 1,170 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2769200 PORT SIDE STRATEGIES, LLC 1bbe5953-16f6-4a89-ae89-7db7150b1009 1T PORT SIDE STRATEGIES, LLC 401105394 SIXTEEN THIRTY FUND 2022 first_quarter PHA Lobbied in support of including drug pricing reforms in the reconciliation bill/Build Back Better Act. Lobbied in support of efforts to lower drug prices through march-in or government use rights. H.R. 6392 - No Tax Breaks for Drug Ads Act -- in support. HOUSE OF REPRESENTATIVES,SENATE     0 1 2022-03-17T13:17:07-04:00
2769675 PENN AVENUE PARTNERS 4e1165f7-04c8-4cd0-a7f7-46c1e1407c10 Q1 PENN AVENUE PARTNERS 400918672 ALKERMES, INC. 2022 first_quarter PHA Regulatory and legislative issues impacting Alkermes. S.3593 - Telehealth Extension and Evaluation Act. Public Law No: 117-103 Consolidated Appropriations Act, 2022. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-04T10:28:51-04:00
2769840 PENN AVENUE PARTNERS a03688c3-97a8-4091-9f0b-b559300ed3bb Q1 PENN AVENUE PARTNERS 400918672 UNITEDHEALTH GROUP, INC. 2022 first_quarter PHA Pharmacy benefit related issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office 90000   0 0 2022-04-04T17:44:01-04:00
2769842 AMERICAN COLLEGE OF CLINICAL PHARMACY 7fe58b10-f35c-499a-83fb-6cd4c6644efa Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2022 first_quarter PHA Coverage for direct patient care services of qualified clinical pharmacists under Medicare and other public health programs. HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2022-04-04T17:45:12-04:00
2769864 THORSEN FRENCH ADVOCACY LLC 31a406a2-5562-4362-9be1-25416c42e10d 1T THORSEN FRENCH ADVOCACY LLC 400599826 HEALTHCARE DISTRIBUTION ALLIANCE 2022 first_quarter PHA Issues related to pharmaceutical supply chain resiliency. Issues related to H.R.768/S.__: Block, Report, And Suspend Suspicious Shipments Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2022-04-04T21:34:53-04:00
2769978 MUSCULAR DYSTROPHY ASSOCIATION, INC. 9b17da81-b39a-4ef7-8ae6-23a961f4245d Q1 MUSCULAR DYSTROPHY ASSOCIATION, INC. 400348610 MUSCULAR DYSTROPHY ASSOCIATION, INC. 2022 first_quarter PHA Advocated for funding and implementation of the ACT for ALS, a law that should accelerate development of treatments for individuals with ALS and other neuromuscular diseases. Advocated for the passage of the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (H.R. 5030/S. 2706) Provided feedback and comments to the Senate's PREVENT Act. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2022-04-05T14:19:01-04:00
2770207 CARD & ASSOCIATES, LLC 80b41dd8-767c-4706-9508-5c5ec9e63450 Q1 CARD & ASSOCIATES, LLC 84217 AMAZON.COM (FRA PILLPACK AN AMAZON COMPANY) 2022 first_quarter PHA Monitoring legislation on drug price transparency and market access issues including legislative proposals related to drug pricing Monitoring federal appropriations for FY 2022 Access to telemedicine HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-06T16:01:27-04:00
2770247 STONINGTON GLOBAL d2f1b2a5-f792-4788-873b-2d40559ed0cf Q1 STONINGTON GLOBAL 401105189 SORRENTO THERAPEUTICS, INC. 2022 first_quarter PHA Regulatory approvals and funding for pharmaceutical products and devices Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 150000   0 0 2022-04-06T17:40:20-04:00
2770259 ACG ADVOCACY 886045da-fe03-4643-9f73-5469ef126696 Q1 ACG ADVOCACY 2057 WALGREEN CO. 2022 first_quarter PHA Drug Pricing Policy Issues. Data privacy and DIR fee reform. Counterfeiting Issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-06T18:29:16-04:00
2770369 RAY ANDERSON 7e5ac1c7-47be-4930-a211-009fa4a79133 Q1 RAY ANDERSON 401105487 340B HEALTH 2022 first_quarter PHA Requesting the Secretary of Health and Human Services and HRSA to enforce a statute ordering drug companies to restore 340B discounts to eligible hospitals Requesting Centers for Medicare and Medicaid Services to restore the Medicare hospital Outpatient Prospective Payment System reimbursement rate Requested Representative Spanberger and Representative Danny K. Davis and members of the Congressional Black Caucus participation in a Congressional Special Order Hour session. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA) 15000   0 0 2022-04-07T14:24:13-04:00
2770673 VICKI J HICKS f2492735-ab4d-4b1b-8055-741327b3530e Q1 VICKI J HICKS 401106146 A2 STRATEGIES, LLC OBO PHIBRO ANIMAL HEALTH CORPORATION 2022 first_quarter PHA Animal health issues. SENATE 10000   0 0 2022-04-08T11:28:54-04:00
2770684 MCDERMOTT+ LLC 563b81d1-a87e-42a0-bf44-544e2ace32cd Q1 MCDERMOTT+ LLC 401103287 ALLIANCE FOR RURAL HOSPITAL ACCESS 2022 first_quarter PHA Amendments to Section 340B of the Public Health Service Act regarding eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program, including the Closing Loopholes for Orphan Drugs Act (H.R. 853). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-08T11:48:12-04:00
2770797 HOLLAND & KNIGHT LLP 5b340f3b-f305-4058-a230-3935b9bbb00f Q1 HOLLAND & KNIGHT LLP 18466 VIATRIS INC 2022 first_quarter PHA Drug shortages, formulary tiering, Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021 (H.R. 2846), biosimilar uptake, Medicare generics penalty, generic drugs issues, supply chain issues, e-labeling provision in the FY2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill (H.R. 4356), and Military Construction, Veterans Affairs, and Related Agencies appropriations bill (H.R. 4355), Prescription Drug Pricing Dashboard Act (S. 1773); drug pricing; Build Back Better Act (H.R. 5376); Enhanced Access to Affordable Medicines Act of 2022 (H.R. 6973); Increasing Transparency in Generic Drug Applications Act of 2022 (H.R. 7032); Generic Drug User Fee Amendments. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-08T16:18:13-04:00
2771076 CONNECT 4 STRATEGIES, LLC 0bc01ccf-fba0-4ee3-a189-ae22caf51910 Q1 CONNECT 4 STRATEGIES, LLC 401103720 OREXO US, INC. 2022 first_quarter PHA Legislative and regulatory issues pertaining to Orexo Implementation of the SUPPORT act. Access to Digital Therapeutics (S3532) MAT Digital Therapeutics Support Recovery Act. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-09T19:26:20-04:00
2771382 POLSINELLI PC 28625e2a-6981-4879-b165-6f97e5aae5f8 Q1 POLSINELLI PC 314911 TEVA PHARMACEUTICALS USA, INC. 2022 first_quarter PHA Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products Review of Administration telehealth policies HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-11T11:46:38-04:00
2771645 PANNONE LOPES DEVEREAUX & O'GARA LLC db06a7fe-52ba-4d34-a7d6-f3504f18a059 Q1 PANNONE LOPES DEVEREAUX & O'GARA LLC 401105501 AMGEN 2022 first_quarter PHA Prescription drug pricing.   9000   0 0 2022-04-11T16:40:13-04:00
2771815 AMERICAN PHARMACISTS ASSOCIATION 4dd1cff4-6dff-480d-b120-0beed0556848 Q1 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2022 first_quarter PHA H.R. 3554/S.1909 The Pharmacy DIR Reform To Reduce Senior Drug Costs Act, to amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes. H.R. 3662 -- The Patient Access to Urgent-Use Pharmacy Compounding Act of 2021, to amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain urgent-use compounded medications, and for other purposes. H.R. 3682 --To amend title XI of the Social Security Act to provide greater transparency for discounts provided by manufacturers. H.R. 2608 --Ensuring Seniors Access to Local Pharmacies Act of 2021, a bill that establishes several requirements for prescription drug plans under the Medicare prescription drug benefit. H.R. 7213 - To amend title XVIII of the Social Security Act to provide pharmacy reimbursement for COVID-19-related and future emergency services. HOUSE OF REPRESENTATIVES,SENATE   35000 0 0 2022-04-12T09:34:20-04:00
2771879 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING d575133d-a719-48db-8316-d331f0bc254f Q1 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2022 first_quarter PHA Compounding, preparation, packaging and dispensing of radiopharmaceuticals Food & Drug Administration (FDA)   60000 0 0 2022-04-12T10:29:48-04:00
2772208 ACADEMY OF MANAGED CARE PHARMACY 4b18f3f2-177b-472f-b178-6d867ef08e69 Q1 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2022 first_quarter PHA Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products HOUSE OF REPRESENTATIVES,SENATE   110000 0 0 2022-04-12T14:08:43-04:00
2772492 INDEPENDENT PHARMACY COOPERATIVE dc17e493-9cbf-4fbc-9871-e7271c204832 Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2022 first_quarter PHA IPC supports S. 1909/H.R. 3554, the Pharmacy DIR Reform to Reduce Senior Drug Costs Act. Support regulations/laws that would eliminate pharmacy DIR. Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs(CMS-4192-P). Support with amendments. IPC supports Pharmacists as Providers under Medicare Part B. IPC supports Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 2759/S. 1362 IPC supports Pharmacists as Immunizers IPC supports 340B Program and contract pharmacies IPC supports Federal Retail Pharmacy COVID-19 Vaccination Program expansion. IPC supports MCO Medicaid reform and elimination of spread pricing Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   30000 0 0 2022-04-12T17:55:26-04:00
2772528 LUNGREN LOPINA LLC f458006b-0317-4cbf-bb02-2361dedbfcd8 Q1 LUNGREN LOPINA LLC 401103314 AMPAC FINE CHEMICALS 2022 first_quarter PHA Fair treatment for US based pharmaceutical ingredients HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-12T20:19:59-04:00
2772609 PUBLIC CITIZEN ff9af9af-b94d-4724-b3bd-dd9224963597 Q1 PUBLIC CITIZEN 32362 PUBLIC CITIZEN 2022 first_quarter PHA HR 5376-Build Back Better Act-drug pricing measures, pandemic preparedness and vaccine manufacturing, HR 6000 (CURES 2.0) antimicrobial development provisions, HR 4502-FY22 Consolidated Appropriations Act-Covid-19 vaccine manufacturing, Affordable Insulin NOW Act, Discounted drugs for clinical trials act, Pharmaceutical Research and transparency, S 2891-Restoring the America Invents Act, HR 4521-America COMPETES act, Plain prescription Prices act, S 3799-PREVENT Pandemics Act, COVID 19 vaccine manufacturing and delivery. HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2022-04-13T09:38:09-04:00
2773031 KOUNTOUPES DENHAM CARR & REID, LLC 0dcdcb6e-2524-49dd-acc9-6c7c33fa141b Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 GLENMARK PHARMACEUTICALS, INC., USA 2022 first_quarter PHA Issues related to affordability, essential medicine manufacturing and pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. Issues related to pharmaceutical provisions in H.R. 5376, the Build Back Better Act. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-13T15:08:40-04:00
2773640 TARPLIN, DOWNS & YOUNG, LLC 1e1e4a1c-8809-49f1-9b2b-575817efe799 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2022 first_quarter PHA Drug coverage & reimbursement vaccination user fees no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-14T10:53:06-04:00
2773840 TARPLIN, DOWNS & YOUNG, LLC 7fec83a6-fea7-4934-bd50-d8ef32b3f38a Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2022 first_quarter PHA no specific bills, drug safety, prescription drug importation, import safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, innovation, transparency HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-14T12:20:39-04:00
2773939 TARPLIN, DOWNS & YOUNG, LLC 7a4fda1e-0570-4a08-a859-123b7d665011 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2022 first_quarter PHA ppioid abuse - general issues related to opioid abuse; issues related to ARCOS data and suspicious order record requirements and reporting (HR 768), user fee reauthorization Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-14T13:04:04-04:00
2774321 DESIMONE CONSULTING, LLC 71457dcb-fe26-4237-b565-339c3ba748c5 Q1 DESIMONE CONSULTING, LLC 400931695 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2022 first_quarter PHA Issues related to patient access and pricing; Issues related to policy changes to Medicare Part D; PDUFA Reauthorization; FY2022 Budget Reconciliation (H.R.5376). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-14T15:20:46-04:00
2774635 GOVERNMENT COUNSEL, LLC 6ee397d6-314f-49dc-a7f8-213680a80bb4 Q1 GOVERNMENT COUNSEL, LLC 401105070 HEALTHCARE DISTRIBUTION ALLIANCE 2022 first_quarter PHA Implementation of Public Law 113-54 (DSCSA). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-14T18:17:15-04:00
2774642 DAVE KOLBE CONSULTING 138ac413-eb25-4546-ada9-707582779e3f Q1 DAVE KOLBE CONSULTING 401104329 PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION 2022 first_quarter PHA Reauthorization of the Prescription Drug User Fee Act (PDUFA) - Support for a strong PDUFA reauthorization that ensures Americans will continue to have first access to life-saving biopharmaceutical medicines throughout the length of the reauthorization. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-14T18:50:31-04:00
2774683 FOLEY & LARDNER LLP 60dd0078-572b-4f9b-9bc1-91002a25db80 Q1 FOLEY & LARDNER LLP 15042 BLINK HEALTH LTD (A BERMUDA LIMITED COMPANY) 2022 first_quarter PHA Market-based solutions to drug pricing and chain pharmacy barriers to generic pharmaceutical price reduction. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-14T23:08:34-04:00
2774808 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER fcee4152-0716-4b1a-bb86-796730c86dfd Q1 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2022 first_quarter PHA 340B, white bagging, PDUFA Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   34560 0 0 2022-04-15T09:18:52-04:00
2775263 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 3e55dc4f-89e9-4e3b-bdc1-943ffd7c4a5d Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2022 first_quarter PHA S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021; H.R. 3655, the Vaccine Injury Compensation Modernization Act of 2021; H.R. 3656, the Vaccine Access Improvement Act of 2021; H.R. 3662, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2021; COVID vaccine distribution; Pharmacist scope of practice, including authorities established by the Public Readiness and Emergency Preparedness (PREP) Act; H.R. 4390, the PROTECT 340B Act of 2021; S. 1574 / H.R. 5632, the Long-Term Care Pharmacy Definition Act of 2021; Provider Relief Fund; Implementation of Pubic Law 113-54, the Drug Quality and Security Act; H.R. 6005, the Access to Birth Control Act; H.R. 6000, Cures 2.0 Act; H.R. 6519, Patients Right to Know Their Medication Act of 2022; Draft legislation, Pharmacy Price Transparency Protection Act; Draft legislation, Prescription Information Modernization Act; Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   2010000 0 0 2022-04-15T12:47:27-04:00
2775577 NELSON MULLINS RILEY & SCARBOROUGH b4ca2e8f-04ab-456f-b255-392954bbf08a Q1 NELSON MULLINS RILEY & SCARBOROUGH 285871 HEMOPHILIA OF GEORGIA 2022 first_quarter PHA 340B Drug Pricing Program, Medicare, patient co-pay policies HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-04-15T14:37:06-04:00
2775781 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH 0b6b8537-f9af-49ed-8509-289181a22a30 Q1 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH 401104060 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH 2022 first_quarter PHA General education around pharmaceuticals related to Parkinson's disease Increasing drug affordability and accessibility via drug pricing, Medicare Part D redesign and benefits, and streamlining prior authorization processes and step therapy protocols Prescription Drug User Fee Act H.R. 4417, the Capping Drug Costs for Seniors Act H.R. 4479/S. 2609, the Facilitating Innovative Nuclear Diagnostics Act of 2021 S. 2327, the Seniors Prescription Drug Relief Act H.R. 3173/S. 3018, the Improving Seniors Timely Access to Care Act of 2021 H.R. 2163, the Safe Step Act H.R. 5801, the Help Ensure Lower Patient (HELP) Copays Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   57949 0 0 2022-04-15T16:19:13-04:00
2776101 FORBES-TATE aa9540ac-048f-419f-b039-3ab692de7d8f Q1 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2022 first_quarter PHA Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-15T20:01:24-04:00
2776372 FORBES-TATE cadff849-3f47-4953-8061-8eda7d398998 Q1 FORBES-TATE 400976792 INDEPENDENT PHARMACY COOPERATIVE 2022 first_quarter PHA Issues related to pharmacy regulation, the MAC Transparency Act, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-16T10:54:37-04:00
2776564 FOLEY & LARDNER LLP 46f4bd04-d94e-401f-bdb7-1dd4d8b693f1 Q1 FOLEY & LARDNER LLP 15042 ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY 2022 first_quarter PHA FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2022-04-16T14:44:29-04:00
2776628 CAPITOL COUNSEL LLC 7a01cb6c-473d-4283-9906-89f4108d14fa Q1 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2022 first_quarter PHA Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-16T16:01:12-04:00
2776676 CAPITOL COUNSEL LLC b7e93d32-f8f0-41b9-991e-d44d1b688af2 Q1 CAPITOL COUNSEL LLC 313715 VERTEX PHARMACEUTICALS INCORPORATED 2022 first_quarter PHA Monitoring and advocacy on matters related to the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-16T16:31:13-04:00
2776778 BROYDRICK & ASSOCIATES cb38fd34-dabf-4553-8344-2956ea360ffd Q1 BROYDRICK & ASSOCIATES 7268 TONIX PHARMACEUTICALS 2022 first_quarter PHA Funding new drug for PTSD and COVID 19. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-04-16T17:50:53-04:00
2776813 FOLEY & LARDNER LLP f9ee39d2-c7fd-44b8-a064-b6e1fb0ca34f Q1 FOLEY & LARDNER LLP 15042 FOUNDATION CONSUMER HEALTHCARE LLC 2022 first_quarter PHA Legislation and regulations affecting marketing and commercialization of prescription and non-prescription drugs HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-16T19:17:24-04:00
2777103 FORBES-TATE c3dd45b6-afcd-4ac3-92bb-18c7832622ca Q1 FORBES-TATE 400976792 PHRMA 2022 first_quarter PHA Issues pertaining to prescription drug pricing. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-17T12:10:09-04:00
2777111 BOCKORNY GROUP, INC. 674e787b-45ab-4219-b7e5-645bc3bc1768 Q1 BOCKORNY GROUP, INC. 289773 CVS HEALTH INC 2022 first_quarter PHA Issues related to PBMs Issues related to drug pricing Issues related to health reform proposals Issues related to representation in COVID-19-related packages HR 1319 American Rescue Plan Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2022-04-17T12:12:58-04:00
2777231 RED+BLUE STRATEGIES 6fe6e9bd-4f64-4f7b-b501-ce4373fe95aa Q1 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2022 first_quarter PHA H.R. 2571 Consolidated Appropriations Act for Fiscal Year 2022 - Issues related to the use of rebates and other cost savings tools used by pharmacy benefit managers Issues and legislative vehicles related to capping the price of Insulin. Regulations focused on quality measures used in contracting relationships between pharmacy benefit managers and pharmacies (known as DIR). H.R. 5376 - The Build Back Better Act - Support of full repeal of the Trump Administration's Rebate Rule. PL 117-2 - The American Rescue Plan Act - Implementation of policies related to increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2022-04-17T14:49:04-04:00
2777307 ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) 9abb46fc-2034-4421-a594-264255f3bef1 Q1 ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) 400762305 AMERISOURCEBERGEN CORPORATION 2022 first_quarter PHA Issues related to drug pricing and transparency, generally. Issues related to the importation of prescription medicines Issues related to the pharmaceutical supply chain and stockpiling Issues related to COVID vaccine distribution HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-17T16:02:31-04:00
2777343 ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) 743981bc-a9be-4270-8b88-799ec2d4a3a3 Q1 ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) 400762305 PHRMA (PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA) 2022 first_quarter PHA Issues relating to drug pricing, value and transparency, generally. Issues relating to medical research and development, as well as access to medicines HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-17T16:20:58-04:00
2777483 FORBES-TATE 10a970a3-31ad-4d54-8c81-5e9892faab19 1T FORBES-TATE 400976792 VERDE TECHNOLOGIES 2022 first_quarter PHA Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE     0 1 2022-04-17T19:21:08-04:00
2777598 CORNERSTONE GOVERNMENT AFFAIRS, INC. 9bd7417b-a541-4c94-a2f1-f905ac53e70c Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CHILDREN'S NATIONAL MEDICAL CENTER 2022 first_quarter PHA Representation on health-related issues including reimbursement, research, public-health & clinical care Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2022-04-17T21:49:00-04:00
2777686 MARSHALL & POPP, LLC 6b071f1c-f9ea-4637-aa9a-b314d51e7279 Q1 MARSHALL & POPP, LLC 401105121 AMGEN USA INC. 2022 first_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act; H.R.5376, the Build Back Better Act, and budget reconciliation recommendations released by Senate committees pursuant to S.Con.Res. 14. Issues related to supply chains, 340B, and the COVID-19 pandemic. H.R.2471, Consolidated Appropriations Act, issues related to 340B and ESRD. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T06:41:42-04:00
2777692 MARSHALL & POPP, LLC b654b8fe-adde-444d-a230-bb32d6579364 Q1 MARSHALL & POPP, LLC 401105121 BUTTERFLY NETWORK, INC. 2022 first_quarter PHA Issues related to medical device manufacturing / insurance / technology, including S.3799, the PREVENT Pandemics Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T06:45:44-04:00
2778131 FAEGRE DRINKER BIDDLE & REATH LLP 0bb3ed15-6294-4f96-98a7-24877d3cdc6d Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 NATIONAL ASSOCIATION OF BOARDS OF PHARMACY 2022 first_quarter PHA Medication safety, pharmacy regulation and licensure, and the opioid epidemic; Prescription drug monitoring programs; COVID-19 response; H.R.2482, S. 2074 - Mainstreaming Addiction Treatment Act; Prescription drug importation; H.R. 6352, S. 3399 - Domain Reform for Unlawful Drug Sellers Act. Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-18T11:00:11-04:00
2778244 AMERICAN VETERINARY MEDICAL ASSOCIATION cee6f881-d049-47e3-8751-7bf94a5ac7c8 Q1 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2022 first_quarter PHA -Review of Food and Drug Administrations Draft guidance #256 for industry: Compounding Animal Drugs from Bulk Drug Substance Prescription Mandate legislation Animal Drug User Fee Act/ Animal Generic Drug User Fee Act reauthorization Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 320000   0 0 2022-04-18T11:19:34-04:00
2778427 LINCOLN PARK GROUP L.L.C. aec8b081-ae4a-4331-84d0-c75dfef2b0b7 Q1 LINCOLN PARK GROUP L.L.C. 401104374 CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2022 first_quarter PHA Support for S. 920/H.R. 2181 - A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals and S. 259/H.R. 832 - Safe and Affordable Drugs from Canada Act; S. 3399/H.R. 6532 Domain Reform for Unlawful Drug Sellers Act; S. 3984, Stop Illegal Online Sales of Controlled Substances Act; and other issues related to personal drug importation. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-18T11:51:47-04:00
2778512 UNIVERSITY OF IOWA f317819a-7343-4d29-b261-db5cf36abf1f Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2022 first_quarter PHA N/A HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2022-04-18T12:08:43-04:00
2778595 MLJ STRATEGIES bf98d0ef-2a21-43d4-96a7-11b4de5ee050 Q1 MLJ STRATEGIES 401105126 ANKURA CONSULTING GROUP, LLC ON BEHALF OF ON DEMAND PHARMACEUTICALS 2022 first_quarter PHA Advocating on issues related to pharmaceutical appropriations HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-18T12:23:23-04:00
2778642 MLJ STRATEGIES 3827784a-80a0-4154-ae02-af6aa33a5418 Q1 MLJ STRATEGIES 401105126 ANKURA CONSULTING GROUP, LLC ON BEHALF OF THORNE RESEARCH 2022 first_quarter PHA Advocate on issues related to supplement use in the military HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-18T12:27:25-04:00
2778878 KOUNTOUPES DENHAM CARR & REID, LLC 6cbb8f34-dc48-4a9c-a389-7a2ecef3c7e0 Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) 2022 first_quarter PHA Issues related to generic pharmaceuticals and biosimilars, including reimbursement rate, pricing, and supply chain. Issues related to H.R. 2853, BLOCKING Act of 2021. Issues related to pharmaceutical patents. Issues related to drug pricing measures in H.R. 5376, the Build Back Better Act. Issues related to FDA provisions in S. 3799, the PREVENT Pandemics Act. Issues related to the Generic Drug User Fee Act (GDUFA). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T13:00:56-04:00
2778998 K&L GATES, LLP db0037ff-3349-46e3-857e-5746080e54b4 Q1 K&L GATES, LLP 32098 PRN SOFTWARE 2022 first_quarter PHA Issues related to COVID-19 antiviral deployment - no specific legislation. White House Office 30000   0 0 2022-04-18T13:19:36-04:00
2779164 KOUNTOUPES DENHAM CARR & REID, LLC 85360a73-9b93-47a8-8bff-5b4bbfcedaf2 Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) 2022 first_quarter PHA Issues related to proposals that would address drug shortages and national stockpile issues, including H.R. 2870, the Essential Medicines Strategic Stockpile Act of 2021. Issues related to COVID-19 vaccine distribution. Issues related to pharmacy provider status. Issues related to pharmaceutical supply chain provisions in S. 3799, PREVENT Pandemics Act. Issues related to drug pricing in H.R. 5376, the Build Back Better Act. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T13:50:13-04:00
2779654 BLUECROSS BLUESHIELD OF TENNESSEE ec0918d8-0512-4dde-9e88-d6b747d45ba2 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2022 first_quarter PHA COVID-19 Testing; Vaccine Strategy and Treatment; Prescription Drug Reform Educated Congressional Members on our Specialty Pharmacy Program and Savings We've Seen Thus Far H.R. 3 - Lower Drug Costs Now Act Sponsor: Rep. Frank Pallone HOUSE OF REPRESENTATIVES,SENATE   330000 0 0 2022-04-18T15:06:40-04:00
2779798 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 9dcf2407-b08d-47a2-bf2e-88e61cf0a1c4 Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2022 first_quarter PHA Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Conversation with DEA regulation on Medication-Assisted Treatment and drug shortages. Discussed COVID-19 response recommendations with House and Senate Offices, White House Offices, and HHS and its sub-agencies, and DEA. Contact HHS, House and Senate Offices concerning rule enforcement of the 340B Drug Pricing Program. Met with House and Senate offices to discuss the Protect 340B Act (H.R. 4390) and bills S.773 and H.R. 3203, also related to the 340B program. Discussed role out of Test to Treat Program with HHS and its agencies. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   355000 0 0 2022-04-18T15:26:49-04:00
2779939 THERMO FISHER SCIENTIFIC INC. 8c12cc10-dc39-4dd5-b08f-ae99a457b97b Q1 THERMO FISHER SCIENTIFIC INC. 323251 THERMO FISHER SCIENTIFIC INC 2022 first_quarter PHA Worker training program (H.R. 5993). Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   740000 0 0 2022-04-18T15:58:31-04:00
2780576 MCDERMOTT+ LLC 2b8f61a1-9b5e-4211-8178-36e823d10197 Q1 MCDERMOTT+ LLC 401103287 CAMPAIGN FOR SUSTAINABLE DRUG PRICING 2022 first_quarter PHA S. 1391 - Fair Accountability and Innovative Research Drug Pricing Act. Prescription drug pricing issues. Patent abuse issues. Ensuring Innovation Act and the Advancing Education on Biosimilars Act of 2021. Drug-price Transparency for Competition (DTC) Act. H.R. 5376 - Build Back Better Act. Prescription Drug User Fee Act. H.R. 6833 - Affordable Insulin Now Act. National Coverage Determination on Aduhelm. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 30000   0 0 2022-04-18T17:44:00-04:00
2780799 PORT SIDE STRATEGIES, LLC 26cd25ed-820a-424f-bec3-7e47d60f42d0 Q1 PORT SIDE STRATEGIES, LLC 401105394 NEW VENTURE FUND 2022 first_quarter PHA Lobbied in support of including drug pricing reforms in the reconciliation bill. HOUSE OF REPRESENTATIVES,SENATE     0 0 2022-04-18T19:33:25-04:00
2780892 BLUESTONE STRATEGIES, LLC cbebd08f-2229-43fd-8a06-877bd1ab86e0 Q1 BLUESTONE STRATEGIES, LLC 400658980 AMERICA'S HEALTH INSURANCE PLANS (AHIP) 2022 first_quarter PHA HR 3, Lower Drug Costs Now Act; HR 5260, Reduced Cost and Continued Care Act; Specialty Drugs and Prescription Drug Pricing, HR 19. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T20:17:22-04:00
2780932 BLUESTONE STRATEGIES, LLC dce39f4c-fc9c-45f4-bd1a-113e012aabb4 Q1 BLUESTONE STRATEGIES, LLC 400658980 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2022 first_quarter PHA Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T20:34:16-04:00
2780972 MARSHALL & POPP, LLC 01be289e-900d-45fd-a147-f82633135703 Q1 MARSHALL & POPP, LLC 401105121 GENENTECH, INC. 2022 first_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R.22/S.2164, the Lower Costs, More Cures Act; H.R.5376, the Build Back Better Act, and budget reconciliation recommendations released by Senate committees pursuant to S.Con.Res. 14. Issues related to supply chains, 340B, and the COVID-19 pandemic. H.R.2471, Consolidated Appropriations Act, issues related to 340B. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T21:02:29-04:00
2781004 MARSHALL & POPP, LLC ef103652-5673-44f0-98d2-ab2edb1f1f30 Q1 MARSHALL & POPP, LLC 401105121 PFIZER, INC. 2022 first_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R.22/S.2164, the Lower Costs, More Cures Act; H.R.5376, the Build Back Better Act, and budget reconciliation recommendations released by Senate committees pursuant to S.Con.Res. 14. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. H.R.2471, Consolidated Appropriations Act, issues related to 340B. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T21:17:58-04:00
2781009 MARSHALL & POPP, LLC 9b3430ba-a93c-431d-bbf5-ac94c096b895 Q1 MARSHALL & POPP, LLC 401105121 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2022 first_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R.22/S. 2164, the Lower Costs, More Cures Act; H.R.5376, the Build Back Better Act, and budget reconciliation recommendations released by Senate committees pursuant to S.Con.Res.14. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. H.R.2471, Consolidated Appropriations Act, issues related to 340B. Issues related to insulin, including H.R.6833, Affordable Insulin Now Act. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-18T21:21:43-04:00
2781013 MARSHALL & POPP, LLC 82669abc-733c-4674-9a77-ac3939d3c21c Q1 MARSHALL & POPP, LLC 401105121 SANOFI U.S. SERVICES, INC. 2022 first_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R.22/S.2164, the Lower Costs, More Cures Act; H.R.5376, the Build Back Better Act, and budget reconciliation recommendations released by Senate committees pursuant to S.Con.Res.14. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. H.R.2471, Consolidated Appropriations Act, issues related to 340B. Issues related to insulin, including H.R.6833, Affordable Insulin Now Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-18T21:24:17-04:00
2781514 TRAVERE THERAPEUTICS 53431626-f2f2-4ea2-8a4f-41d262a5b989 Q1 TRAVERE THERAPEUTICS 401104190 TRAVERE THERAPEUTICS 2022 first_quarter PHA H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and related Senate legislation. H.R. 19, Lower Costs More Cures Act. Legislative proposals regarding drug pricing, value, and reimbursement in H.R. 5736 Build Back Better Act and related Senate legislation. HOUSE OF REPRESENTATIVES,SENATE   210000 0 0 2022-04-19T08:43:25-04:00
2781684 VAN SCOYOC ASSOCIATES fdca8dfd-66c1-44f5-badf-08be552a42c7 Q1 VAN SCOYOC ASSOCIATES 39837 ZEBRA TECHNOLOGIES CORP. 2022 first_quarter PHA Temperature monitoring technology for COVID vaccines, Domestic and International distribution related issues Temperature monitoring technology, COVID Rapid Diagnostic Test Kits S.3799, PREVENT Pandemics Act, Rapid Diagnostic Test related issues HOUSE OF REPRESENTATIVES 30000   0 0 2022-04-19T09:11:40-04:00
2781880 CONCERNED WOMEN FOR AMERICA LEGISLATIVE ACTION COMMITTEE e9bfd651-dd91-4417-81c6-905301d534e1 Q1 CONCERNED WOMEN FOR AMERICA LEGISLATIVE ACTION COMMITTEE 47985 CONCERNED WOMEN FOR AMERICA LEGISLATIVE ACTION COMMITTEE 2022 first_quarter PHA Lobbied Senate against Dr. Robert Califf's nomination to be Commissioner of the Food and Drug Administration due to his weakening of the REMS for the chemical abortion pill SENATE   9000 0 0 2022-04-19T09:28:51-04:00
2781986 MEHLMAN CONSULTING, INC. 09b0f0d2-4d8c-4dd2-a709-a87722be8a80 1T MEHLMAN CONSULTING, INC. 284950 AMNEAL 2022 first_quarter PHA Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs. Pandemic Preparedness. H.R. 5376 - Build Back Better Act. S. 3799 - PREVENT Pandemics Act. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 1 2022-04-19T09:38:06-04:00
2782359 BUCHANAN INGERSOLL & ROONEY PC 534a9804-d614-489b-8075-ab627d5e09a8 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 FERA PHARMACEUTICALS, LLC 2022 first_quarter PHA Strategy development and implementation of federal government relations initiatives relating to phospholine iodide issues with the Food and Drug Administration and Centers for Medicare and Medicaid Services. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2022-04-19T10:11:05-04:00
2782426 BUCHANAN INGERSOLL & ROONEY PC c61ee09f-0b9e-48f8-bb98-1f744938de54 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2022 first_quarter PHA Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-19T10:15:06-04:00
2782561 KOUNTOUPES DENHAM CARR & REID, LLC 095393aa-cec4-4770-a19e-69124cf01d5c Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2022 first_quarter PHA General issues related to over-the-counter pharmaceutical supply chain. Issues related to dietary supplements. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-19T10:28:39-04:00
2782611 WATKINS & EAGER PLLC 950235cc-780a-4d25-9b25-a1c453b32d73 Q1 WATKINS & EAGER PLLC 401104403 ZYNERBA PHARMACEUTICALS, INC. 2022 first_quarter PHA Providing services on behalf of Zynerba to the pharmaceutical industry - looking for testing sites Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-19T10:31:47-04:00
2782723 ELI LILLY AND COMPANY 1df8b4fa-530c-4fe6-82e3-612eeb8bee0b Q1 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2022 first_quarter PHA Hospital discounts; 340B program; Affordable Prescriptions for Patients Act of 2021 (S.1435) HOUSE OF REPRESENTATIVES,SENATE   1510000 0 0 2022-04-19T10:40:56-04:00
2782855 BLUE CROSS AND BLUE SHIELD ASSOCIATION 0da5d816-b539-4582-b704-ca8bdba93454 Q1 BLUE CROSS AND BLUE SHIELD ASSOCIATION 6358 BLUE CROSS AND BLUE SHIELD ASSOCIATION 2022 first_quarter PHA COVID-19 Testing; Rx reform; Prescription drugs; Prescription Drug Reform; OTC COVID Tests; Insulin; H.R. 3 - Lower Drug Costs Now Act Sponsor: Rep. Frank Pallone (D-NJ-06) Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   1450000 0 0 2022-04-19T10:51:22-04:00
2782887 VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) 5003d998-f245-45aa-be80-c7d9575edbd2 Q1 VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) 401103475 RX SAVINGS, LLC DBA RX SAVINGS SOLUTIONS 2022 first_quarter PHA Issues related to healthcare consumerism and pharmacy transparency. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2022-04-19T10:53:48-04:00
2783251 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 8dda1318-ed85-4e9e-a565-cffd5cd8df22 Q1 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2022 first_quarter PHA OTC switch process -- no bill number Cures 2.0 -- no bill number S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 Prescription Drug User Fee Act (PDUFA) -- no bill number Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   156000 0 0 2022-04-19T11:17:31-04:00
2783285 BOLD STRATEGIES, LLC 00c4d738-849d-4fdd-a337-0b3f7cc9afe7 Q1 BOLD STRATEGIES, LLC 401104653 MORRIS & DICKSON CO., LLC 2022 first_quarter PHA Prescription drug issues generally. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2022-04-19T11:20:00-04:00
2783577 TWENTY-FIRST CENTURY GROUP, INC. 83a28a2d-735c-4784-91d7-e1931a568dac Q1 TWENTY-FIRST CENTURY GROUP, INC. 38687 CARDINAL HEALTH, INC. 2022 first_quarter PHA Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19 pandemic response; and the healthcare supply chain. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-19T11:43:32-04:00
2783655 WAXMAN STRATEGIES eaac0a21-7886-4208-9716-f66efe3311a0 Q1 WAXMAN STRATEGIES 401103693 340B HEALTH 2022 first_quarter PHA Issues affecting the 340B drug pricing program; Appropriations for 340B program. HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2022-04-19T11:51:12-04:00
2784512 RED+BLUE STRATEGIES 7a536919-5a25-4dfe-8ec8-a8ef54f113db Q1 RED+BLUE STRATEGIES 400693064 COHERUS BIOSCIENCES 2022 first_quarter PHA S. 3991 - American Made Pharmaceuticals Act - Support for policies that increase the ability for medications across the spectrum to be developed, manufactured and distributed in the US. H.R. 5376 - Build Back Better Act - Continued advocacy for issues related to supporting the growth of biosimilars in America to provide competition and tools to lower the cost of prescription medications S. 164 - Biosimilars Education Act of 2021 - A bill to raise awareness of the efficacy and promise of biosimilars in the American health care system. Issues and policies that incent companies to increase their US footprint and adopt Made in America business practices. Policies to help grow the biosimilars marketplace in the United States. Policies focused on improving cancer care through access to affordable treatments. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-19T13:04:58-04:00
2784590 E3 STRATEGIC CONSULTING GROUP 8e0ac182-3a0a-452a-9fdc-4ba2f62d7f53 Q1 E3 STRATEGIC CONSULTING GROUP 401104104 HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) 2022 first_quarter PHA Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HOUSE OF REPRESENTATIVES 30000   0 0 2022-04-19T13:11:52-04:00
2784600 E3 STRATEGIC CONSULTING GROUP 7b10b6cb-265d-4a64-aa69-cb8f003d8e0d Q1 E3 STRATEGIC CONSULTING GROUP 401104104 PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION 2022 first_quarter PHA Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HOUSE OF REPRESENTATIVES 20000   0 0 2022-04-19T13:12:43-04:00
2784896 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 1e265db3-2322-4f52-99a9-57cb2828c52d Q1 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 6382 BLUE CROSS AND BLUE SHIELD OF FLORIDA INC 2022 first_quarter PHA COVID-19 Testing; Rx Reform; Prescription Drugs; Prescription Drug Reform; OTC COVID-19 Tests; Insulin HR 3 (117th Congress), Elijah E. Cummings Lower Drug Costs Now Act, by Rep. Frank Pallone (D-NJ). Establishes a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   240000 0 0 2022-04-19T13:42:29-04:00
2784965 GUIDEWELL MUTUAL HOLDING CORPORATION 729e6c4f-8b47-4b5e-9fad-31ed7b6331a2 Q1 GUIDEWELL MUTUAL HOLDING CORPORATION 401103191 GUIDEWELL MUTUAL HOLDING CORPORATION 2022 first_quarter PHA COVID-19 Testing; Rx Reform; Prescription Drugs; Prescription Drug Reform; OTC COVID-19 Tests; Insulin HR 3 (117th Congress), Elijah E. Cummings Lower Drug Costs Now Act, by Rep. Frank Pallone (D-NJ). Establishes a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office     0 0 2022-04-19T13:48:08-04:00
2785572 KOUNTOUPES DENHAM CARR & REID, LLC 7b010a5f-493d-4ed6-9cfe-89fb6439661a Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CVS HEALTH 2022 first_quarter PHA General education about the pharmacy benefit manager/pharmacy and insurance industry. Issues related to drug pricing. Issues related to the drug supply chain. Issues related to the implementation of H.R. 1319, The American Rescue Plan, including provisions related to vaccine distribution. Issues related to the Fiscal Year 2022 budget reconciliation process focusing on drug pricing, including H.R. 5376, the Build Back Better Act. Issues related to pharmacy provider status. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2022-04-19T14:44:07-04:00
2785772 REPUBLIC CONSULTING, LLC 34b30993-6f86-4b91-95d8-637155c38d10 Q1 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2022 first_quarter PHA Monitored Health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 60000   0 0 2022-04-19T14:58:31-04:00
2786295 BROWN & FORTUNATO, P.C. 25a3e987-8fdb-4a7f-b437-02c09f021191 Q1 BROWN & FORTUNATO, P.C. 401104878 PROMPTCARE COMPANIES, INC. 2022 first_quarter PHA Issues related to Medicare home infusion therapy benefit and other health care issues. Issues related to the Medicare DMEPOS competitive bidding program and Medicare coverage and payment for non-invasive ventilators. Centers For Medicare and Medicaid Services (CMS) 20000   0 0 2022-04-19T15:30:39-04:00
2786868 AKIN GUMP STRAUSS HAUER & FELD 406bdc94-acc9-4bdb-927d-d37a56a4a409 Q1 AKIN GUMP STRAUSS HAUER & FELD 682 UNITED STATES PHARMACOPEIAL CONVENTION 2022 first_quarter PHA Compounding; Drug Pricing; 21st Century Cures Act 2.0; COVID-19 pandemic response; Supply chain reform; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations; Cannabis; Infrastructure and budget reconciliation legislation. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2022-04-19T16:13:53-04:00
2787007 AARP e6e53049-e7f7-4ac3-80cc-06cdd8e43bb6 Q1 AARP 1694 AARP 2022 first_quarter PHA No bill number. Discussed prescription drug legislation and policies to lower prescription drug prices. H.R.5376, the Build Back Better Act. S.3700/H.R.6833, the Affordable Insulin Now Act. No bill number. Discussed disclosure of prescription drug prices in television ads. No bill number. Discussed inappropriate use of antipsychotic drugs in nursing homes. H.R. 4356, the FY 2022 Agriculture, Rural Development & FDA Appropriations. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   3530000 0 0 2022-04-19T16:23:06-04:00
2787071 HANCE SCARBOROUGH 93147ef9-df5f-4a80-9368-31fe4c532eba Q1 HANCE SCARBOROUGH 17443 ALLIANCE FOR PHARMACY COMPOUNDING 2022 first_quarter PHA Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2022 Appropriations HR3662, the Patient Access to Urgent Use Compounded Medication Act HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2022-04-19T16:27:00-04:00
2787240 HANCE SCARBOROUGH 990bfc96-a9ac-4646-b377-7e8d2e0e7a32 Q1 HANCE SCARBOROUGH 17443 PHRMA 2022 first_quarter PHA Patent reform regarding pharmaceutical research & products. SENATE 30000   0 0 2022-04-19T16:38:35-04:00
2787298 RAMPY NORTHRUP LLC 00f2f6a6-08c9-49ff-9bb2-1db451516e52 Q1 RAMPY NORTHRUP LLC 401103289 ASTRAZENECA PHARMACEUTICALS LP 2022 first_quarter PHA Provide legislative and regulatory advice related to vaccine development, drug pricing, the 340B Drug Pricing Program, PDUFA Reauthorization, and clinical trial diversity; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; H.R.6000, Cures 2.0 Act; FY2022 Budget Reconciliation (H.R.5376); H.R.5585, Advanced Research Project Agency-Health Act; H.R.5030/S.2706, DIVERSE Trials Act. HOUSE OF REPRESENTATIVES 60000   0 0 2022-04-19T16:40:55-04:00
2787600 RICCHETTI INCORPORATED 56470a95-b06d-4abb-86ac-7e3439581022 Q1 RICCHETTI INCORPORATED 62778 EISAI, INC. 2022 first_quarter PHA Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs; Drug pricing and access, and Medicare and Medicaid reimbursement; Issues related to pharmaceutical industry, generally HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2022-04-19T17:01:24-04:00
2787628 SQUIRE PATTON BOGGS 2e84b74b-a974-4c84-8f19-cae468525995 Q1 SQUIRE PATTON BOGGS 30906 SK HYNIX AMERICA, INC. 2022 first_quarter PHA Monitor proposals and issues related to biopharmaceuticals. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2022-04-19T17:04:14-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2091.988ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API